GSK supports green manufacturing R&D through new Singapore grants
This article was originally published in Scrip
Executive Summary
GlaxoSmithKline and the Economic Development Board (EDB) of Singapore have awarded the first grants under a joint S$33 million ($23.6 million) fund to support research in the field of environmentally considerate pharmaceutical and fine chemical manufacturing technology.